Blogs Oliver Joins DCI from Huntsman Cancer Institute Published August 18, 2022 Related News News Mention Izalontamab Brengitecan Shows Promising Clinical Activity in Previously Treated Extensive-Stage Small Cell Lung Cancer July 28, 2026 Oncology Learning Network News Mention NCI Funds Study Led by Dr. Hui-Kuan Lin Aiming to Unlock New Therapies for KRas-Driven Cancers July 01, 2026 Duke Pathology Related News News Mention Izalontamab Brengitecan Shows Promising Clinical Activity in Previously Treated Extensive-Stage Small Cell Lung Cancer July 28, 2026 Oncology Learning Network News Mention NCI Funds Study Led by Dr. Hui-Kuan Lin Aiming to Unlock New Therapies for KRas-Driven Cancers July 01, 2026 Duke Pathology
News Mention Izalontamab Brengitecan Shows Promising Clinical Activity in Previously Treated Extensive-Stage Small Cell Lung Cancer July 28, 2026 Oncology Learning Network
News Mention NCI Funds Study Led by Dr. Hui-Kuan Lin Aiming to Unlock New Therapies for KRas-Driven Cancers July 01, 2026 Duke Pathology
News Mention Izalontamab Brengitecan Shows Promising Clinical Activity in Previously Treated Extensive-Stage Small Cell Lung Cancer July 28, 2026 Oncology Learning Network
News Mention NCI Funds Study Led by Dr. Hui-Kuan Lin Aiming to Unlock New Therapies for KRas-Driven Cancers July 01, 2026 Duke Pathology
